DUBLIN , July 22, 2022 /PRNewswire/ -- The "Disposable Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
The global disposable syringes market reached a value of US$ 13.01 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 20.5 Billion by 2027, exhibiting a CAGR of 7.87% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Disposable syringes are widely utilized for injecting medicines through intravenous or intramuscular ways to treat different diseases. They are plastic syringes designed for one-time use in the medical, veterinary, and research and development (R&D) fields. They are cheaper compared to traditional syringes without any maintenance costs. They assist in maintaining the safety of the patients while reducing the chances of cross-contamination. At present, there is a rise in the use of disposable syringes to support the diagnosis and treatment of various chronic diseases, such as heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza, and pneumonia. This, along with the growing number of surgeries across the globe, represents one of the key factors driving the market.
In addition, there is an increase in the number of patients suffering from acquired immune deficiency syndrome (AIDS) around the world due to unprotected sexual contact and contact with infected blood. This, coupled with the burgeoning healthcare industry, is propelling the growth of the market. Besides this, key market players are focusing on efficient sterilizing surgery while avoiding infections among healthcare practitioners and patients, especially after the outbreak of the coronavirus disease (COVID-19) pandemic.
Moreover, the growing incidences of needlestick injuries among patients are catalyzing the demand for disposable syringes. Besides this, the rising trend of self-injecting medicines is offering lucrative growth opportunities to industry investors. Apart from this, governments of several countries are undertaking initiatives to encourage the adoption of disposable medical supplies for preventing the spread of infections in operating rooms. These initiatives are projected to bolster the growth of the market in the coming years.
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, Henke-Sass Wolf GmbH, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Terumo Corporation and Vita Needle Company.
Key Questions Answered in This Report:
How has the global disposable syringes market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global disposable syringes market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global disposable syringes market and who are the key players?
What is the degree of competition in the industry?
Key Topics Covered: 1 Preface 2 Scope and Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Disposable Syringes Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product Type 6.1 Conventional Syringes 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Safety Syringes 6.2.1 Market Trends 6.2.2 Key Segments 6.2.2.1 Retractable Safety Syringes 6.2.2.2 Non-Retractable Safety Syringes 6.2.3 Market Forecast 7 Market Breakup by Application 7.1 Immunization Injections 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Therapeutic Injections 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Diagnostic Laboratories 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Others 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 B. Braun Melsungen AG 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 SWOT Analysis 14.3.2 Baxter International Inc. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.2.3 Financials 14.3.3 Becton Dickinson and Company 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Cardinal Health Inc. 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Fresenius SE & Co. KGaA 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 Henke-Sass Wolf GmbH 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 Nipro Corporation 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Novo Nordisk A/S 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 Retractable Technologies Inc. 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.10 Terumo Corporation 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.10.4 SWOT Analysis 14.3.11 Vita Needle Company 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio
For more information about this report visit https://www.researchandmarkets.com/r/lfbfp6
Media Contact: Laura Wood , Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/the-worldwide-disposable-syringes-industry-is-expected-to-reach-20-5-billion-by-2027--301591751.html
Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.
Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Yahoo Finance Editor-in-Chief Andy Serwer discusses Berkshire's stake in Occidental Petroleum and what that indicates to investors.
Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).
Michael Burry, who bet on the collapse of subprime credit, does not hesitate to give his opinion on market developments.
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.
(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla
Yahoo Finance's Pras Subramanian discusses the latest auto news from the Tesla-only lane at the U.S.-Mexico border to Volkswagen replacing its CEO.
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fiscal fourth-quarter results.
Yahoo Finance's Brian Cheung and Akiko Fujita discuss Snap earnings and analyst reratings on the stock.
As demand for natural gas around the world soars, the focus in the United States has turned to building the infrastructure for the next stage of the LNG boom
Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.
Stock-market bulls are poking their heads above the parapet, but skeptics see little more than a bear-market bounce.
(Bloomberg) -- Volkswagen AG abruptly ousted Herbert Diess, its chief executive officer and architect of the auto industry’s biggest electrification effort, after repeated clashes with labor unions chipped away at his support with key stakeholders.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Int
Just where is the stock market going, that’s the question investors are trying to answer. The answer isn’t fully clear, though; markets have fallen for most of this year, but the last few days have seen the best trading in weeks. The problem is, investors and economists aren’t sure if we’re at a true bottom or just in the midst of a bear market rally. What happens next is anyone’s guess, but the history of bears and rallies can offer some suggestions. Looking back to the end of the Second World
The Dow Jones fought back. Tesla stock rocketed after Elon Musk gave an update on its "best product ever." Apple stock popped. Bitcoin fell.